News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Trevena, Inc. (TRVN) To Host Conference Call To Discuss Second Quarter 2014 Results On August 12


8/5/2014 9:54:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that it will host a conference call on Tuesday, August 12, 2014 at 8:30 a.m. EDT to discuss its financial and operational results for the second quarter ended June 30, 2014. The company will issue a press release reporting its results at approximately 7:00 a.m. EDT on August 12.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES